OrthoPediatrics (NASDAQ:KIDS – Get Rating) had its price objective increased by investment analysts at Truist Financial from $53.00 to $57.00 in a report issued on Monday, The Fly reports. Truist Financial’s price objective indicates a potential upside of 17.67% from the company’s previous close. Several other equities research analysts also recently issued reports on KIDS. […]